Cargando…
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
BACKGROUND: Reovirus type 3 Dearing strain (ReoT3D) has an inherent propensity to preferentially infect and destroy cancer cells. The oncolytic activity of ReoT3D as a single agent has been demonstrated in vitro and in vivo against various cancers, including colon, pancreatic, ovarian and breast can...
Autores principales: | Sei, Shizuko, Mussio, Jodie K, Yang, Quan-en, Nagashima, Kunio, Parchment, Ralph E, Coffey, Matthew C, Shoemaker, Robert H, Tomaszewski, Joseph E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723073/ https://www.ncbi.nlm.nih.gov/pubmed/19594950 http://dx.doi.org/10.1186/1476-4598-8-47 |
Ejemplares similares
-
Oncolytic Reovirus in Canine Mast Cell Tumor
por: Hwang, Chung Chew, et al.
Publicado: (2013) -
Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2017) -
The oncolytic effects of reovirus in canine solid tumor cell
lines
por: IGASE, Masaya, et al.
Publicado: (2015) -
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
por: Heinemann, Lucy, et al.
Publicado: (2011) -
Correction: Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2018)